MedTrace Logo

Ocular Imaging With Spectral Domain Optical Coherence Tomography

NCT00926549 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2009-06-23

No results posted yet for this study

Summary

The purpose of this study is to analyze macular retinal thickness and macular volume using the spectral domain - optical coherence tomography (SD-OCT) in normal eyes and in eyes with various ocular diseases.

Conditions

  • Healthy
  • Myopia
  • Hypermetropia

Interventions

DEVICE

Spectral domain-OCT (Cirrus™ HD-OCT, Carl Zeiss Meditec AG)

macular cube scanning

Sponsors & Collaborators

  • Yonsei University

    lead OTHER

Principal Investigators

  • Sung Soo Kim, MD, PhD · Department of Ophthalmology, Yonsei University College of Medicine, Gangnam Severance Hospital

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
16 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2009-09-30
Completion
2009-09-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00926549 on ClinicalTrials.gov